Experimental pharmacokinetics of a new antiparkinsonian drug ADK-1113

The pharmacokinetics of a new antiparkinsonian drug ADK-1113 after single intravenous and intragastric administrations in mice at doses of 10 and 20 mg/kg was studied. The absolute bioavailability was 10.1-16.3 % that indicates on potential possibility of preparing a dosage form for oral administrat...

Full description

Saved in:
Bibliographic Details
Main Authors: O. Yu. Kravtsova (Author), D. A. Dvoryaninov (Author), G. B. Kolyvanov (Author), A. A. Litvin (Author), O. G. Gribakina (Author), V. P. Zherdev (Author)
Format: Book
Published: LLC "Publisher OKI", 2024-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available